Twist Bioscience Corp TWST:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/23/21 EDT
120.14quote price arrow up+1.35 (+1.14%)
Volume
397,228
52 week range
40.01 - 214.07

...

Loading . . .
  • Open118.34
  • Day High122.00
  • Day Low118.34
  • Prev Close120.14
  • 52 Week High214.07
  • 52 Week High Date01/21/21
  • 52 Week Low40.01
  • 52 Week Low Date06/25/20

Key Stats

  • Market Cap5.874B
  • Shares Out48.89M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-14.97

KEY STATS

  • Open118.34
  • Day High122.00
  • Day Low118.34
  • Prev Close120.14
  • 52 Week High214.07
  • 52 Week High Date01/21/21
  • 52 Week Low40.01
  • 52 Week Low Date06/25/20
  • Market Cap5.874B
  • Shares Out48.89M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change-14.97

RATIOS/PROFITABILITY

  • EPS (TTM)-2.72
  • P/E (TTM)-44.23
  • Fwd P/E (NTM)-38.66
  • EBITDA (MRQ)-114.772M
  • ROE (MRQ)-28.08%
  • Revenue (MRQ)113.00M
  • Gross Margin (MRQ)36.96%
  • Net Margin (MRQ)-109.15%
  • Debt To Equity (MRQ)0.52%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Twist Bioscience Corp

There is no recent news for this security.

Profile

MORE
Twist Bioscience Corporation is a synthetic biology company. The Company is developing a disruptive deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company has a semiconductor-based synthetic DNA manufacturing process featuring 10,000-well silicon platform, which is capable of producing synthetic biology tools, such as genes, oligonucleotide pools and variant libraries. Its silicon-based DNA writing platform offers synthesis of...
Emily Leproust Ph.D.
Chairman
Patrick Weiss
Chief Operating Officer
James Thorburn
Chief Financial Officer
Siyuan Chen
Chief Technology Officer
Address
681 GATEWAY BLVD.
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
ADPT
Adaptive Biotechnologies Corp
40.96+1.26+3.17%
PACB
Pacific Biosciences of California Inc
31.40+1.15+3.80%
NTLA
Intellia Therapeutics Inc
83.59+4.68+5.93%
BHVN
Biohaven Pharmaceutical Holding Company Ltd
97.72+0.52+0.53%
VIR
Vir Biotechnology Inc
47.10-0.57-1.20%